Background Thrombocytopenia has been shown to occur soon after surgical biological
aortic valve replacement (AVR), and recently reported also after transcatheter valve …

Thrombocytopenia and impaired platelet function are known as intrinsic drawbacks of
cardiac surgery and extracorporeal life supports (ECLS). A number of different factors …

OBJECTIVES Platelet count reduction is a common but not fully understood phenomenon
after aortic valve replacement (AVR) with bioprosthesis implantation. The aim of the present …

Abstract Objective The Perceval S bioprosthesis (LivaNova PLC, London, United Kingdom)
is based on the Freedom Solo aortic bioprosthesis (LivaNova PLC), which has been …

Introduction: The incidence of postoperative thrombocytopenia after aortic valve
replacement (AVR) with the Perceval S Sutureless bioprosthesis remains unclear. The aim …

Methods: Between July 2004 and September 2006, a total of 256 patients (116 males; 140
females; mean age 74.5±6.4 years; range: 41-89 years) who underwent AVR with the …

OBJECTIVES: Use of the Freedom SOLO (SOLO) stentless aortic bioprosthesis is
associated with a unique, and as yet unexplained, observation of postoperative low platelet …

Objectives To determine the incidence and etiology of thrombocytopenia following
transcatheter Aortic valve replacement (TAVR). Background the use of TAVR in the United …

Methods: The data were analyzed from all patients undergoing AVR with (n= 829) or without
(n= 1,230) coronary artery bypass grafting (CABG) at a single center between January 1998 …

BACKGROUND: The incidence of postoperative thrombocytopenia after aortic valve
replacement with the Freedom Solo bioprosthesis remains unclear. This propensity-matched …